Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients’ poor response to treatment and short-term relapse - Concepedia

Concepedia

Publication | Open Access

Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients’ poor response to treatment and short-term relapse

DOI Full Paper Access

11

Citations

31

References

2015

Year

Lamprini Stamati, Margaritis Avgeris, Helen Kosmidis, Margarita Baka, Theodora Anastasiou, Despina Piatopoulou, Andreas Scorilas, Dimitrios Gourgiotis

Journal of Cancer Research and Clinical Oncology

Hematological MalignancyBfm Induction TherapyMedicineMalignant Blood DisorderPharmacotherapyShort-term RelapseOncologyRadiation OncologyNovel TherapyCancer ResearchMolecular Medicine

References

	Year	Citations

Page 1

Page 1